7Baggers
 precision biosciences announces $70m stock offering  MSN Fri, 14 Nov 2025 03:52:56 GMT
 Precision BioSciences Announces Stock Offering and Warrants  TradingView Wed, 12 Nov 2025 14:15:01 GMT
 Precision BioSciences Announces $70M Stock Offering  MSN Wed, 12 Nov 2025 06:22:30 GMT
 Precision BioSciences (DTIL) Announces $75 Million Stock Offerin  GuruFocus Tue, 11 Nov 2025 08:18:38 GMT
 Precision BioSciences (DTIL) Launches $75 Million Stock and Warr  GuruFocus Tue, 11 Nov 2025 04:26:08 GMT
 precision biosciences raises $75 million in stock and warrant offering  Investing.com Tue, 11 Nov 2025 00:03:45 GMT
 precision biosciences (dtil) launches $75 million stock and warr  GuruFocus Mon, 10 Nov 2025 23:55:31 GMT
 Precision BioSciences Inc Updates on ELIMINATE-B Clinical Trial  TradingView Mon, 10 Nov 2025 22:25:00 GMT
 precision biosciences (nasdaq:dtil) ceo sells $22,124.41 in stock  MarketBeat Wed, 05 Nov 2025 21:52:05 GMT
 precision biosciences reports q3 2025 financial results  TipRanks Wed, 05 Nov 2025 05:00:42 GMT
 Precision BioSciences Reports Q3 2025 Financial Results  TipRanks Tue, 04 Nov 2025 08:00:00 GMT
 precision biosciences: q3 earnings snapshot  ctinsider.com Tue, 04 Nov 2025 06:35:49 GMT
 Precision BioSciences (DTIL) Exceeds Q3 Revenue Expectations  GuruFocus Mon, 03 Nov 2025 13:25:09 GMT
 precision biosciences reports q3 eps ($1.84), consensus ($2.21)  TipRanks Mon, 03 Nov 2025 12:14:07 GMT
 Precision BioSciences Q3 revenue falls sharply  TradingView Mon, 03 Nov 2025 12:10:31 GMT
 PRECISION BIOSCIENCES INC SEC 10-Q Report  TradingView Mon, 03 Nov 2025 12:03:00 GMT
 Precision BioSciences Inc Reports Q3 2025 EPS of -$1.84, Missing  GuruFocus Mon, 03 Nov 2025 08:00:00 GMT
 Precision BioSciences: Q3 Earnings Snapshot  San Francisco Chronicle Mon, 03 Nov 2025 08:00:00 GMT
 what makes dentsply sirona inc. stock price move sharply  newser.com Sun, 02 Nov 2025 16:47:28 GMT
 Imugene to explore discussions with FDA, triggering Precision BioSciences milestone  Proactive financial news Sun, 02 Nov 2025 07:00:00 GMT
 precision biosciences, inc. (nasdaq:dtil) short interest update  MarketBeat Sat, 01 Nov 2025 02:11:02 GMT

Precision BioSciences, Inc
(NASDAQ:DTIL) 

DTIL stock logo

Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States. The company operates through two segments, Therapeutic and Food. It offers ARCUS, a genome editing platform to cure genetic disorders. The Therapeutic segment develops allogeneic CAR T immunoth...

Founded: 2006
CEO: Matthew Kane  
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology

Share this website to your friends